ClinicalTrials.gg
Drug

Decitabine clinical trials

Also written Dacogen and DAC.

studies test it
277
open now
51
in phase 3
30
first study started
1995

Counted the way a researcher would: Decitabine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Decitabine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Decitabine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
2 May 2006 · DACOGEN · NDA 021790 (FDA, Drugs@FDA)
European Union
20 Sept 2012 · Dacogen · EMEA/H/C/002221 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Decitabine
209
Deoxyazacytidine
35
Dezocitidine
35
5-Aza-2'-deoxycytidine
33
Decitabine for Injection
32

Brand

Dacogen
112

Development codes

EPI01
1
DW1018
1

Other names

DAC
24

In one entry with another drug

Given together, or one or the other

Decitabine/cedazuridine
4
Oral decitabine/cedazuridine
2
Oral Decitabine and Tetrahydrouridine
2
Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
2

Studies by the year they started

276 studies that test it; most in 2017 (19); 1 more planned to start later

Studies that test Decitabine, by start year
YearStudies
19951
19971
19981
19991
20012
20027
20034
20046
20056
20068
20077
200812
200912
201010
20119
201211
201314
201414
201511
201612
201719
201816
201911
202010
20217
202211
202313
202410
202513
202617

Who runs them

Industry 33 · Other 244

M.D. Anderson Cancer Center (32) · National Cancer Institute (NCI) (28) · The First Affiliated Hospital of Soochow University (10) · Eisai Inc. (9) · Ruijin Hospital (9) · Chinese PLA General Hospital (7) · Nanfang Hospital, Southern Medical University (6) · Roswell Park Cancer Institute (5)

Often tested with

Tested in the same studies.

Venetoclax (31) · Cytarabine (26) · Azacitidine (17) · Cedazuridine (11) · Vorinostat (8) · Tetrahydrouridine (8) · Sorafenib (5) · Fludarabine (5)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Decitabine is the comparator. A study of two new drugs counts under both.

  • 1Galinpepimut-s · Sellas Life Sciences Group
  • 1Clifutinib · Sunshine Lake Pharma Co., Ltd. · next primary completion Nov 2027
Reaching primary completion within a year · 15

Studies that test Decitabine.

Studies

Open first, then newest update. How each study uses Decitabine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 277

See all 277 studies that test Decitabine →

Given beside what is tested · 107 — Decitabine is usual care or a partner of the new treatment

Showing 20 of 107.

As the comparator · 6 — what is tested is compared with Decitabine

What changed recently

From the registry's own updates since Oct 17, 2026.

Results posted1

Codes

What other systems call Decitabine · ClinicalTrials.gg INT006664

  • MeSH (NLM) D000077209DecitabineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 776B62CQ27DECITABINEConfirmed FDA, NLM, Wikidata
  • RxNorm 15657Confirmed FDA, Wikidata
  • Wikidata Q1181878decitabineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C981DecitabineOne source FDA
  • DrugBank DB01262One source Wikidata

Also registered as decitabine mesylate (UNII 6U3LPL9PRN).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.